AM152
Phase 2- Indications
- Idiopathic pulmonary fibrosis, Systemic sclerosis
Company intelligence / Profile preview
Amira Pharmaceuticals
San Diego, California, United Statesamiratx.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Phase 2
01
Overview
Amira Pharmaceuticals developed small molecule drugs targeting inflammatory and fibrotic diseases. Its lead compound, AM152, an LPA1 antagonist for IPF and SSc, completed Phase I with encouraging results. The company also advanced FLAP inhibitors in partnership with GSK for respiratory/cardiovascular disease. Upon acquisition by Bristol Myers Squibb in September 2011, the pipeline included several early-stage assets focused on bioactive lipid pathways.
- Therapeutic areas
- PulmonologyImmunologyRheumatologyCardiovascularNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
GlaxoSmithKline – partnership on FLAP inhibitors for respiratory/cardiovascular disease ($425M potential deal value).
Beyond the preview
Go deeper on Amira Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amira Pharmaceuticals.